0.037
0.00 (4.48%)
| Previous Close | 0.036 |
| Open | 0.990 |
| Volume | 21,050 |
| Avg. Volume (3M) | 10,339 |
| 52 Weeks Range |
| Profit Margin | -102.77% |
| Operating Margin (TTM) | -105.91% |
| Quarterly Revenue Growth (YOY) | 5.40% |
| Total Debt/Equity (MRQ) | 8.62% |
| Current Ratio (MRQ) | 2.40 |
| Operating Cash Flow (TTM) | -11.51 M |
| Levered Free Cash Flow (TTM) | -2.25 M |
| Return on Assets (TTM) | -23.39% |
| Return on Equity (TTM) | -61.27% |
AIStockmoo Score
| Value 60% | -0.1 |
| Low debt. Weak profitability. Ample short-term liquidity. Negative cash flow. info | |
| From our AI Insight report's view of expected return against risk. info | NA |
| Relative Valuation info | NA |
| Implied Growth info | NA |
| Valuation History info | NA |
| Return on Capital info | NA |
| Earnings Trend info | NA |
| Holdings' Value info | NA |
| Risk Premium info | NA |
| Market Valuation info | NA |
| Timing | NA |
| From our AI technical analysis of the chart. info | NA |
| Trend Strength info | NA |
| Technical Setup info | NA |
| Candle Patterns info | NA |
| Medium-Term Trend info | NA |
| Sentiment 40% | 0.0 |
| No recent price targets, so based on how targets have been revised. info | |
| Holdings' Sentiment info | NA |
| News Mood info | NA |
| Smart Money | NA |
| Insider Activity info | NA |
| Institutional Flow info | NA |
| Short Interest info | NA |
| Market and sector conditions are poor. | |
| Market environment cautious. info | |
| Sector outperforming the market. | |
| No pillar has a clear reading, so the score is unchanged. | |
| Not in score | |
| Price Volatility info | NA |
| No clear trend across the short, medium and long term. info | |
| No clear signal from support and resistance. info | |
| Final Score | -0.06 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Clever Leaves Holdings Inc. | - | - |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B | Score |
|---|---|---|---|---|---|
| CLVRW | - | - | - | - | -0.1 |
| ZYBT | 72 M | - | - | 2.13 | -1.7 |
| SHPH | 17 M | - | - | 0.200 | -2.4 |
| CANB | 2 M | - | 0.233 | 33.49 | -1.4 |
| CYTHW | - | - | - | - | -3.1 |
| BIOA | - | - | - | 0.680 | -1.9 |
Select this tab to load the latest available analysis.
|
Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, standardized extracts, and oral solutions, as well as tetrahydrocannabinol flower. The company was incorporated in 2017 and is based in Tocancipá, Colombia. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |